Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (91-100 of 271) with videos related to

Pageof 28
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 19, 2009
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of diseaseRaghunandan Vikram, Chaan S Ng, Pheroze Tamboli, et al.
The Journal of Urology|February 13, 2014
Partial nephrectomy in the setting of metastatic renal cell carcinomaKara N Babaian, Megan M Merrill, Surena Matin, et al.
Current Medical Research and Opinion|July 2, 2014
Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practicesEric Jonasch, James E Signorovitch, Peggy L Lin, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
Journal of Medical Economics|December 15, 2015
Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the USSumanta K Pal, Eric Jonasch, James E Signorovitch, et al.
BMC Cancer|April 23, 2015
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinomaThai H Ho, Xian-De Liu, Yanqing Huang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosisFederico A Monzon, Karla Alvarez, Lief Peterson, et al.
Oncogene|July 11, 2019
MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinomaNathanael H Green, Daniel L Galvan, Shawn S Badal, et al.
European Urology Open Science|March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 CountriesRachel Giles, Deborah Maskens, Robert Bick, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Pageof 28

Showing results (91-100 of 271) with videos related to

Sort By:
Pageof 28
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 19, 2009
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of diseaseRaghunandan Vikram, Chaan S Ng, Pheroze Tamboli, et al.
The Journal of Urology|February 13, 2014
Partial nephrectomy in the setting of metastatic renal cell carcinomaKara N Babaian, Megan M Merrill, Surena Matin, et al.
Current Medical Research and Opinion|July 2, 2014
Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practicesEric Jonasch, James E Signorovitch, Peggy L Lin, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
Journal of Medical Economics|December 15, 2015
Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the USSumanta K Pal, Eric Jonasch, James E Signorovitch, et al.
BMC Cancer|April 23, 2015
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinomaThai H Ho, Xian-De Liu, Yanqing Huang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosisFederico A Monzon, Karla Alvarez, Lief Peterson, et al.
Oncogene|July 11, 2019
MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinomaNathanael H Green, Daniel L Galvan, Shawn S Badal, et al.
European Urology Open Science|March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 CountriesRachel Giles, Deborah Maskens, Robert Bick, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Pageof 28